Sono Tek CORP

Market Movers (8-K)

See all →
NASDAQ
Sono-Tek Corporation announced a robust first quarter for fiscal year 2027, with a 10% increase in net sales and significant improvements in profitability driven by strong medical sector demand.
Better than expected
NASDAQ
Sono-Tek Corporation achieved its second consecutive year of over $20 million in revenue and an 81% increase in operating income for fiscal year 2026.
NASDAQ
Sono-Tek Corporation reported its seventh consecutive quarter of over $5 million in revenue, with gross margin expanding to 50% and record backlog of $12.3 million, despite a slight dip in net sales.
NASDAQ
Sono-Tek Corporation has entered into new executive agreements with its top officers, enhancing change of control protections.
NASDAQ
Sono-Tek Corporation reported strong fiscal second quarter and record first half 2026 financial results, driven by significant growth in the medical market and an increased backlog.
Delay expected
Better than expected
NASDAQ
Sono-Tek Corporation announced a $2.8 million order for advanced medical device coating systems from an existing major U.S. manufacturer, with deliveries expected in the first half of 2026.
Better than expected

Quarterly Earnings (10-Q)

See all →
NASDAQ
Sono-Tek Corporation announced a 10% increase in net sales for the first quarter of fiscal year 2027, driven by strong performance in the medical market.
Better than expected
NASDAQ
Sono-Tek Corporation announced a 24% increase in net income for the third quarter of fiscal 2026, driven by improved gross profit margins and operating leverage, despite a slight dip in overall sales.
Better than expected
Delay expected
NASDAQ
Sono-Tek Corporation announced significant increases in net income and operating profit for the second quarter and first half of fiscal 2026, driven by improved gross margins and reduced operating expenses, despite modest sales growth.
Delay expected
Better than expected
NASDAQ
Sono-Tek Corporation announced a significant increase in first-quarter net income and operating profit, fueled by robust sales in the alternative energy sector, even as cash flow from operations declined and a key customer requested a payment delay.
Delay expected
Better than expected
NASDAQ
Sono-Tek Corporation's Q3 2025 results show a decrease in net sales and gross profit, but a significant increase in sales to the alternative energy market.
Worse than expected
NASDAQ
Sono-Tek Corporation's Q2 2025 results show a decrease in net sales and operating income, but a record high backlog and growth in the clean energy and electronics sectors.
Worse than expected

Annual Reports (10-K)

NASDAQ
Sono-Tek Corporation achieved record annual net sales of $20.9 million for fiscal 2026, driven by strong demand in medical and electronics markets.
Capital raise
NASDAQ
Sono-Tek Corporation achieved record net sales of $20.5 million in fiscal year 2025, a 4% increase, primarily fueled by strong demand in the Alternative/Clean Energy market, though gross profit and net income saw a slight decrease.
Capital raise
NASDAQ
Sono-Tek Corporation's fiscal year 2024 saw a significant 31% increase in net sales, reaching $19.7 million, primarily fueled by growth in the alternative/clean energy, industrial, and medical markets.
Better than expected

Insider Trading (Form 4)

See all →
NASDAQ
Stephen James Bagley, CFO of Sono Tek Corp, sold 1,200 shares of common stock on July 27, 2026 for $5.08 per share.
NASDAQ
Stephen James Bagley, CFO of Sono Tek Corp, sold 3,454 shares of common stock on July 23, 2026 for $5.43 per share.
NASDAQ
Christopher L Coccio, a Director of Sono Tek Corp, sold 17,000 shares of common stock on July 21, 2026 for $5.38 per share.
NASDAQ
Brian Lewis Booth of Sono-Tek Corp reports significant stock transactions, including option exercises and share surrenders.
NASDAQ
SONO-TEK Director Lawal Adeniyi acquired 2,400 shares of common stock and exercised 2,400 options at $4.12 per share.
NASDAQ
Sono-Tek Corp. Director Christopher L. Coccio sold 12,320 shares of common stock at a weighted average price of $4.7803 per share under a Rule 10b5-1 trading plan.
Worse than expected

Proxy Statements (Def-14A)

NASDAQ
Sono-Tek Corporation announces its 2026 Annual Meeting of Shareholders, scheduled for August 20, 2026, to elect directors and ratify auditor appointments.
NASDAQ
Sono-Tek Corporation's latest proxy statement outlines the agenda for its August 21, 2025 Annual Meeting, focusing on director elections, auditor ratification, and advisory votes on executive compensation and its frequency.
Worse than expected
NASDAQ
Sono-Tek Corporation's proxy statement details the upcoming annual meeting, director nominations, executive compensation, and auditor ratification.

Schedule 13G - Passive Investments

NASDAQ
Emancipation Management LLC, Circle N Advisors, LLC, and Charles Frumberg have jointly reported beneficial ownership of 34.7% of Sono Tek Corp's common stock as of December 31, 2024.